[ Price : $8.95]
An Inside Medical Devices analysis says drug and medical device companies should consider and comment on a proposed regulation rev...[ Price : $8.95]
The Generic Pharmaceutical Association says a significant investment of time and resources is required to establish an analytical ...[ Price : $8.95]
FDA accepts for filing a Sanofi NDA for lixisenatide, an investigational once-daily prandial GLP-1 receptor agonist for treating a...[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Medsource, New Dawn Nutrition, Specialty Medicine Compounding, and Ultroid Techn...[ Price : $8.95]
Federal Register Notice: FDA releases a guidance: Controlled Correspondence Related to Generic Drug Development.[ Price : $8.95]
Federal Register Notice: FDA releases an ICH guidance: E6(R2) Good Clinical Practice.[ Price : $8.95]
Federal Register Notice: FDA publishes a list of 13 PMAs that have been approved including safety and effectiveness summaries.[ Price : $8.95]
Federal Register Notice: FDA issues a priority review voucher to Wellstat Therapeutics for the pediatric disease product applicati...